Literature DB >> 836536

Increased blood fibrinolytic activity after aspirin ingestion.

L A Moroz.   

Abstract

Fibrinolytic activity of whole blood and of platelet-deficient plasma, measured by 125I-fibrin assay in four normal subjects before and after ingestion of 1.8 g of aspirin, increased 33 to 150 per cent at one to three hours, at plasma salicylate levels of 5 to 18 mg per 100 ml. In two, plasma activity also increased. Fibrinolysis in blood, but not in plasma, increased 66 per cent after sodium salicylate. Sodium salicylate increased fibrinolytic activities of blood and of purified polymorphonuclear leukocytes in vitro, whereas aspirin had little effect. These striking effects of aspirin on cellular and fluid phases of blood fibrinolysis are apparently distinct from known aspirin actions on platelets. Plasma fibrinolytic activity accounted for only 18.8 +/- 12.3 per cent (S.D.) and 17.4 +/- 10.4 per cent of the activity measured in the corresponding whole blood of 11 normal men and 10 normal women, respectively, indicating the importance of cellular elements in normal blood fibrinolysis.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 836536     DOI: 10.1056/NEJM197703102961001

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  13 in total

Review 1.  Aspirin in patients with coronary artery disease: is it simply irresistible?

Authors:  G V Nair; C J Davis; M E McKenzie; D R Lowry; V L Serebruany
Journal:  J Thromb Thrombolysis       Date:  2001-04       Impact factor: 2.300

Review 2.  Antiplatelet drugs: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  John W Eikelboom; Jack Hirsh; Frederick A Spencer; Trevor P Baglin; Jeffrey I Weitz
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

3.  Aspirin for reducing cancer metastases?

Authors:  U K Henschke; G J Luande; J D Choppala
Journal:  J Natl Med Assoc       Date:  1977-08       Impact factor: 1.798

Review 4.  Enhanced spontaneous thrombolysis: a new therapeutic challenge.

Authors:  I B Kovacs; D A Gorog; J Yamamoto
Journal:  J Thromb Thrombolysis       Date:  2006-06       Impact factor: 2.300

5.  Effect of optimization of hemodynamics on fibrinolytic activity and antithrombotic efficacy of external pneumatic calf compression.

Authors:  E W Salzman; G P McManama; A H Shapiro; L K Robertson; A S Donovan; H W Blume; J Sweeney; R D Kamm; M C Johnson; P M Black
Journal:  Ann Surg       Date:  1987-11       Impact factor: 12.969

6.  Decreased fibrinolytic activity in juvenile chronic arthritis.

Authors:  L Mussoni; G Pintucci; G Romano; F De Benedetti; M Massa; A Martini
Journal:  Ann Rheum Dis       Date:  1990-12       Impact factor: 19.103

7.  Maintenance of cardiodynamics with aspirin during abdominal aortic aneurysmectomy (AAA).

Authors:  T Utsunomiya; M M Krausz; B Dunham; J A Mannick; P D Allen; D Shepro; H B Hechtman
Journal:  Ann Surg       Date:  1981-11       Impact factor: 12.969

8.  Aspirin inhibits vascular plasminogen activator activity in vivo. Studies utilizing a new assay to quantify plasminogen activator activity.

Authors:  R I Levin; P C Harpel; D Weil; T S Chang; D B Rifkin
Journal:  J Clin Invest       Date:  1984-08       Impact factor: 14.808

Review 9.  Aspirin in cardiovascular disease.

Authors:  I A Reilly; G A FitzGerald
Journal:  Drugs       Date:  1988-02       Impact factor: 9.546

Review 10.  The evolution of antiplatelet therapy in the treatment of acute coronary syndromes: from aspirin to the present day.

Authors:  Dominick J Angiolillo
Journal:  Drugs       Date:  2012-11-12       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.